Literature DB >> 23651867

A qualitative review of the neurophysiological underpinnings of fatigue in multiple sclerosis.

Afiqah Yusuf1, Lisa Koski.   

Abstract

Fatigue is debilitating in multiple sclerosis (MS) and may have multiple causes. Recent investigations into objectively measurable correlates of fatigue have used transcranial magnetic stimulation (TMS) to examine a range of neurophysiological measures of neural excitability that may be altered in patients with MS. This qualitative review was conducted to test the hypothesis that changes in neural excitability are a contributing factor in MS-related fatigue. A search of the English language literature led to the compilation and synthesis of original research papers in which various aspects of neural excitability and neural transmission were measured using TMS in patients with MS. The resulting papers were classified into three categories of study relevant to fatigue: abnormalities in excitability and their correlation with self-reported fatigue; effects of exercise-induced fatigue on neural excitability; and effects of fatigue medications on neural excitability. Evidence of an association between fatigue and intracortical inhibition is both limited and conflicting, and no evidence suggests associations of fatigue with corticomotor excitability or neuronal conduction. Pharmacologically-induced changes in fatigue were found to correlate with changes in intracortical excitability. No conclusions could be drawn regarding neural excitability and exercise-induced fatigue, due to variability in study populations, outcome measures, and exercise protocols across different studies. Suggestions for future studies in this area are proposed with a view to identifying potentially modifiable factors contributing to fatigue in MS.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23651867     DOI: 10.1016/j.jns.2013.04.012

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Speech-related fatigue and fatigability in Parkinson's disease.

Authors:  Matthew J Makashay; Kevin R Cannard; Nancy Pearl Solomon
Journal:  Clin Linguist Phon       Date:  2014-08-25       Impact factor: 1.346

2.  Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation.

Authors:  Franca Tecchio; Andrea Cancelli; Carlo Cottone; Giancarlo Zito; Patrizio Pasqualetti; Anna Ghazaryan; Paolo Maria Rossini; Maria Maddalena Filippi
Journal:  J Neurol       Date:  2014-05-23       Impact factor: 4.849

3.  Effects on Motor Control of Personalized Neuromodulation Against Multiple Sclerosis Fatigue.

Authors:  Matteo Padalino; Carla Scardino; Giancarlo Zito; Andrea Cancelli; Carlo Cottone; Massimo Bertoli; Eugenia Gianni; Teresa L'Abbate; Elisabetta Trombetta; Camillo Porcaro; Fabiano Bini; Franco Marinozzi; Maria Maddalena Filippi; Franca Tecchio
Journal:  Brain Topogr       Date:  2021-03-03       Impact factor: 3.020

4.  Brain Plasticity Effects of Neuromodulation Against Multiple Sclerosis Fatigue.

Authors:  Franca Tecchio; Andrea Cancelli; Carlo Cottone; Roberta Ferrucci; Maurizio Vergari; Giancarlo Zito; Patrizio Pasqualetti; Maria Maddalena Filippi; Anna Ghazaryan; Domenico Lupoi; Fenne M Smits; Alessandro Giordani; Simone Migliore; Camillo Porcaro; Carlo Salustri; Paolo M Rossini; Alberto Priori
Journal:  Front Neurol       Date:  2015-07-03       Impact factor: 4.003

5.  Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.

Authors:  Emiliano Santarnecchi; Simone Rossi; Sabina Bartalini; Massimo Cincotta; Fabio Giovannelli; Elisa Tatti; Monica Ulivelli
Journal:  Neural Plast       Date:  2015-07-05       Impact factor: 3.599

6.  Cortical neurodynamics changes mediate the efficacy of a personalized neuromodulation against multiple sclerosis fatigue.

Authors:  Camillo Porcaro; Carlo Cottone; Andrea Cancelli; Paolo M Rossini; Giancarlo Zito; Franca Tecchio
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.